Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation
- 7 July 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (1) , 20-24
- https://doi.org/10.1016/j.jacc.2004.02.056
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Coronary stenting in stable patients: Identification of a low-risk subgroup that may not require adjunctive antiplatelet therapyCatheterization and Cardiovascular Interventions, 2003
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002
- Clopidogrel and percutaneous coronary interventionThe Lancet, 2002
- Clopidogrel in invasive management of non-ST-elevation ACSThe Lancet, 2001
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001
- Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary StentingCirculation, 2000
- Effect of Coumarins Started Before Coronary Angioplasty on Acute Complications and Long-Term Follow-UpCirculation, 2000
- A Randomized Comparison of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin After the Placement of Coronary-Artery StentsCirculation, 2000
- The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctionsJournal of the American College of Cardiology, 1998
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996